Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Busch

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
International Journal of Impotence Research|December 6, 2017
Complications, functional and quality of life outcomes following primary and secondary implantation of penile prosthesis at a tertiary referral centerBernhard Ralla, Irena Goranova, Niels Börnstein, et al.
Urologia Internationalis|March 11, 2016
Retrospective Analysis of Fifth-Line Targeted Therapy Efficacy in Patients with Metastatic Renal Cell CarcinomaBernhard Ralla, Barbara Erber, Irena Goranova, et al.
Investigative Radiology|November 1, 2018
Native T1 Mapping as an In Vivo Biomarker for the Identification of Higher-Grade Renal Cell Carcinoma: Correlation With Histopathological FindingsLisa C Adams, Bernhard Ralla, Philipp Jurmeister, et al.
European Urology|August 2, 2011
Sequence therapy in patients with metastatic renal cell carcinoma: comparison of common targeted treatment options following failure of receptor tyrosine kinase inhibitorsJonas Busch, Christoph Seidel, Carsten Kempkensteffen, et al.
World Journal of Urology|March 11, 2014
Matched comparison of outcomes following open and minimally invasive radical prostatectomy for high-risk patientsJonas Busch, Ahmed Magheli, Natalia Leva, et al.
World Journal of Urology|July 29, 2022
Prognostic factors in patients with clinical stage I nonseminoma-beyond lymphovascular invasion: a systematic reviewFriedemann Zengerling, Dirk Beyersdorff, Jonas Busch, et al.
BJU International|June 8, 2012
Long-term oncological and continence outcomes after laparoscopic radical prostatectomy: a single-centre experienceJonas Busch, Carsten Stephan, Anja Herold, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|May 5, 2018
Renal cell carcinoma with venous extension: prediction of inferior vena cava wall invasion by MRILisa C Adams, Bernhard Ralla, Yi-Na Y Bender, et al.
Cancers|September 12, 2018
miR-9-5p in Nephrectomy Specimens is a Potential Predictor of Primary Resistance to First-Line Treatment with Tyrosine Kinase Inhibitors in Patients with Metastatic Renal Cell CarcinomaBernhard Ralla, Jonas Busch, Anne Flörcken, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 17, 2015
Diagnostic and prognostic potential of circulating cell-free genomic and mitochondrial DNA fragments in clear cell renal cell carcinoma patientsHongbiao Lu, Jonas Busch, Monika Jung, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
International Journal of Impotence Research|December 6, 2017
Complications, functional and quality of life outcomes following primary and secondary implantation of penile prosthesis at a tertiary referral centerBernhard Ralla, Irena Goranova, Niels Börnstein, et al.
Urologia Internationalis|March 11, 2016
Retrospective Analysis of Fifth-Line Targeted Therapy Efficacy in Patients with Metastatic Renal Cell CarcinomaBernhard Ralla, Barbara Erber, Irena Goranova, et al.
Investigative Radiology|November 1, 2018
Native T1 Mapping as an In Vivo Biomarker for the Identification of Higher-Grade Renal Cell Carcinoma: Correlation With Histopathological FindingsLisa C Adams, Bernhard Ralla, Philipp Jurmeister, et al.
European Urology|August 2, 2011
Sequence therapy in patients with metastatic renal cell carcinoma: comparison of common targeted treatment options following failure of receptor tyrosine kinase inhibitorsJonas Busch, Christoph Seidel, Carsten Kempkensteffen, et al.
World Journal of Urology|March 11, 2014
Matched comparison of outcomes following open and minimally invasive radical prostatectomy for high-risk patientsJonas Busch, Ahmed Magheli, Natalia Leva, et al.
World Journal of Urology|July 29, 2022
Prognostic factors in patients with clinical stage I nonseminoma-beyond lymphovascular invasion: a systematic reviewFriedemann Zengerling, Dirk Beyersdorff, Jonas Busch, et al.
BJU International|June 8, 2012
Long-term oncological and continence outcomes after laparoscopic radical prostatectomy: a single-centre experienceJonas Busch, Carsten Stephan, Anja Herold, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|May 5, 2018
Renal cell carcinoma with venous extension: prediction of inferior vena cava wall invasion by MRILisa C Adams, Bernhard Ralla, Yi-Na Y Bender, et al.
Cancers|September 12, 2018
miR-9-5p in Nephrectomy Specimens is a Potential Predictor of Primary Resistance to First-Line Treatment with Tyrosine Kinase Inhibitors in Patients with Metastatic Renal Cell CarcinomaBernhard Ralla, Jonas Busch, Anne Flörcken, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 17, 2015
Diagnostic and prognostic potential of circulating cell-free genomic and mitochondrial DNA fragments in clear cell renal cell carcinoma patientsHongbiao Lu, Jonas Busch, Monika Jung, et al.
Pageof 9